4
Changes in Ownership
Enliven Therapeutics, Inc. Filed Acc 0001415889-24-010676
CHIEF OPERATING OFFICER sold 4,875 shares at an average $18.60 ($90,687)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Patel Anish · CHIEF OPERATING OFFICER
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2024-04-08 | Sale : show line 1 in the form 10b5-1 | −4,331 | $18.50 | $80,134 | 3,141 | D |
| 2024-04-08 | Sale : show line 2 in the form 10b5-1 | −544 | $19.40 | $10,552 | 2,597 | D |
| Open-market sales · 4,875 sh · avg $18.60 · $90,687 | ||||||
Loading xslF345X05/form4-04112024_120405.xml…